Back to Discover

Blood Cancer Journal - Issue - nature.com science feeds

Blood Cancer Journal is a peer-reviewed, open access online journal publishing pre-clinical and clinical work in the field of hematology with ramifications into translational biology research down to new therapies.
71 followers 4 articles/week
Follow
A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping

Blood Cancer Journal, Published online: 03 May 2024; doi:10.1038/s41408-024-01059-xA comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping

Fri May 3, 2024 20:16
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison

Blood Cancer Journal, Published online: 02 May 2024; doi:10.1038/s41408-024-01044-4Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison

Thu May 2, 2024 17:17
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target

Blood Cancer Journal, Published online: 02 May 2024; doi:10.1038/s41408-024-01041-7Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target

Thu May 2, 2024 17:17
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients

Blood Cancer Journal, Published online: 02 May 2024; doi:10.1038/s41408-024-01060-4Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients

Thu May 2, 2024 17:17
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

Blood Cancer Journal, Published online: 29 April 2024; doi:10.1038/s41408-024-01053-3The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

Mon Apr 29, 2024 20:18
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL

Blood Cancer Journal, Published online: 26 April 2024; doi:10.1038/s41408-024-01057-zRapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL

Fri Apr 26, 2024 17:43

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account